Apax Patners sells remaining stake in Galapagos

The shares were sold to European institutional investors. Kempen & Co acted as placement agent on the transaction.

Apax invested in Galapagos in 2002 and the company was later floated on Eurolist-C by Euronext Brussels and Amsterdam in 2005.

Galapagos is a mid-size biotechnology firm specialising in the discovery and development of small molecule and antibody therapies with novel modes-of-action. It has more than 670 employees and operates facilities in six countries, with global headquarters in Mechelen, Belgium.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• France
• UK / Ireland
• Nordics
• Southern Europe
• CEE
• DACH
• Exits
• Healthcare
• Belgium
• Euronext
• Apax Partners